Ola Ibrahim is a pharmaceutical industry leader with extensive experience in patient engagement, access strategy, and the development of patient-centered healthcare programs across the Middle East and Africa. She currently serves as Patient Engagement Manager at Amgen, where she leads initiatives focused on improving patient access, experience, and outcomes.

With over a decade of leadership experience at Eli Lilly and Company, including her role as National Sales Manager for Immunology, Ola has successfully led the launch and expansion of specialized therapeutic areas, while building high-performing teams and implementing national-level strategies. Her work has consistently focused on bridging clinical innovation with real-world patient access through structured patient support programs and cross-functional collaboration.

Her expertise spans biologics, immunology, cardiology, diabetes, and neuroscience, with a strong focus on translating complex therapies into accessible care pathways for patients. She brings deep insight into healthcare systems, market access challenges, and the design of scalable patient engagement models.

Within Amyloidosis Africa, Ola leads the development of patient engagement and access strategies across the continent. Her role focuses on shaping patient pathways, supporting the design of patient support programs, and contributing to partnerships that improve access to diagnosis and treatment for cardiac amyloidosis in diverse African settings.